Mukul Agrawal Enters Recently Listed Specialty Pharma IPO With 1.33% Stake
Veteran investor Mukul Agrawal has made an entry into recently-listed Sudeep Pharma, acquiring 15,00,117 equity shares for an aggregate consideration of INR 85.8 crore, translating into a 1.33% stake. The transaction places Sudeep Pharma firmly on the radar of serious long-term institutional and high-net-worth investors, reinforcing confidence in the company’s post-IPO growth trajectory. This investment […]
Mukul Agrawal Enters Recently Listed Specialty Pharma IPO With 1.33% Stake Read More »







